Symbiotec Pharmalab Ltd

₹1,197.5
-0.90% today
Market Neutral — FadingHealth Care 38.6% in Stage 2-11.1 pts / 20dPharmaceuticals 48.7%-6.7 pts

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

Steady

Edge

—

Is SYMBIOTEC early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
—
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 1
1w13w26w
Week 1, fresh breakout
How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.
vs 200 DMA
—
—
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
—
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↑
Short-term trend rising strongly
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+3.6%
3M
—
6M
—
YTD
—
1Y
—
Sector
Health Care
↓ Peaking
Stage 2%
38.6%
20d Δ
-11.1pp
1M return
-8.6%
3M return
-3.0%
Sector Stage-2 % · last 20 days
Sector has 65 Stage 2 leaders. See Health Care Stage 2 →
Industry
Pharmaceuticals
↓ Peaking
Stage 2%
48.7%
20d Δ
-6.7pp
1M return
-7.1%
3M return
-2.5%
Industry Stage-2 % · last 20 days
Industry has 56 Stage 2 leaders. See Pharmaceuticals Stage 2 →
Stage Cycle Timeline2026-10-22 → 2026-10-22
S? 1w
2026-10-222026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 1w current
Total tracked: 0 weeks across 1 stage run.
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-22S—
Wk 1 · Vol —x
Sector peers in Stage 2All →
BAFNAPH
wk 19 · -4.0% from hi
8.2
KILITCH
wk 4 · -22.5% from hi
6.8
MOREPENLAB
wk 18 · -19.9% from hi
6.5
KOPRAN
wk 21 · -10.1% from hi
6.2
TARSONS
wk 15 · -14.6% from hi
6.2
Moving averages & range
50 DMA
—
200 DMA
—
52W High
—
52W Low
—
5D Low
₹1,197.5
Resistance levels (recent highs)
20d High
₹1,279.5
60d High
—
120d High
—
250d High
—
Next resistance
+6.8%
to 20d High
Ask the Market AI about SYMBIOTECAsk →

Symbiotec Pharmalab: quick answers

Which sector and industry is Symbiotec Pharmalab in?

Symbiotec Pharmalab is in the Pharmaceuticals industry, part of the Health Care sector. 68 stocks in Health Care are in Stage 2, 38.6% of the sector. See the Stage 2 stocks in Pharmaceuticals

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.